Mounjaro®
Starting from £179.99/mo
Start journey Learn moreOmeprazole is a proton-pump inhibitor that reduces stomach acid; weight loss injections such as Mounjaro and Wegovy are GLP-1-based medicines that act on appetite and metabolism. The two are often used together, but they work by entirely different mechanisms and are not connected therapeutically. If you're already taking omeprazole and considering a weight loss injection, the reassuring answer is that co-prescribing is common, though a prescriber must always review your full medication list before any new treatment is started.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
The question comes up for a practical reason. GLP-1 receptor agonists and dual agonists slow the rate at which the stomach empties its contents. That is part of how they reduce appetite. But slowing gastric emptying can also push acid upward, and people who were already prone to reflux sometimes notice it more during the early weeks of treatment or after a dose increase. Omeprazole is frequently already in their medication cabinet. So the real question is usually one of two things: does omeprazole interfere with the injection, or should someone start it to manage new reflux symptoms?
There is a common misconception worth naming and moving past: some people assume omeprazole has some indirect slimming effect because it appears alongside weight-related conditions or because they feel less able to eat comfortably while taking it. It does not cause weight loss. Any change in weight while on a PPI alone is coincidental or explained by something else going on in a person's health or diet.
The clinical picture is genuinely straightforward once you separate the two drug classes. The weight loss injections licensed in the UK are administered subcutaneously (under the skin) so omeprazole's effects on gastric pH are irrelevant to absorption of the active medicine.
No, not directly. Subcutaneous injections deliver medicine into the layer of fat beneath the skin, from where it enters the bloodstream. The gastrointestinal tract is not involved in absorption at that stage, so an acid-suppressing tablet taken by mouth has no meaningful effect on how much tirzepatide or semaglutide reaches systemic circulation. The NHS medicines information for tirzepatide and semaglutide does not list omeprazole as a clinically significant interaction for the injectable forms.
Where things get slightly more nuanced is with oral semaglutide tablets. The Wegovy pill (25mg maintenance, approved by the MHRA in June 2026) relies on an absorption enhancer that works in a specific gastric-pH window. Taking it alongside a PPI that substantially reduces stomach acid may theoretically reduce absorption. The SmPC for oral semaglutide should be checked and the prescriber consulted before combining them. That is a detail worth knowing, because the injectable and tablet forms behave very differently at the absorption stage.
If you are considering the injectable route and already take omeprazole regularly, the interaction question is unlikely to be the deciding clinical factor. The prescriber will weigh your full health picture, including any other medicines. For anyone who finds it more convenient to receive treatment at home, we offer weight loss injections delivered to your door, with full prescriber review included. You can find broader context on what licensed injections are available and how they are reviewed on our weight loss injection pricing and treatment page.
This is where the two medicines do have a practical relationship. Nausea, reflux, indigestion and upper abdominal discomfort are among the most commonly reported side effects of GLP-1-based injections, particularly at the start of treatment or after moving to a higher dose. For people who develop significant heartburn or acid reflux alongside the injection, a prescriber may recommend or continue omeprazole for symptomatic relief. That is a supportive, not a therapeutic, combination.
According to the NHS medicines page for tirzepatide, gastrointestinal effects are the most frequently reported side effects across the class. They are typically mild to moderate and tend to settle within a couple of weeks. Not everyone needs additional support; many manage with dietary adjustments such as smaller, lower-fat meals and staying upright after eating. For those who do need something more, a prescriber can advise on whether a PPI is appropriate and at what dose. That conversation belongs in a clinical consultation, not a general information page.
If you want a clearer picture of what the GI side-effect profile looks like across different injections, the comparison of the main licensed weight loss injections covers this alongside efficacy data. If you are also researching a specific option beginning with r, our guide to the weight loss injection r sets out how it works and what to expect. The NHS provides detailed patient-level information on tirzepatide on its medicines page for tirzepatide, which is worth reading before starting treatment.
List it. That is the short answer. Any clinical consultation for a prescription medicine should include a full medicines review, and omeprazole is no exception. It is one of the most widely taken medicines in the UK and routinely appears in patients' records alongside weight-related conditions such as type 2 diabetes, hypertension and sleep apnoea, conditions that also feature heavily in the eligibility criteria for weight loss injections.
A prescriber reviewing your case will consider whether omeprazole is still appropriate, whether the weight loss injection might affect how acid symptoms behave, and whether your current dose of omeprazole needs any adjustment. At nume, every consultation is personally reviewed by a GPhC-registered Independent Prescriber, a real clinician reads your answers and medical history before any prescription decision is made. That process includes looking at existing medications. If you take omeprazole or any other regular medicine, include it when you complete the consultation form. Our clinical team and prescribing process are described in full on our about page if you want to understand what that review looks like in practice.
For anyone ready to take the next step, you can speak to our prescribers about whether a licensed weight loss injection is clinically suitable for you.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.